Can public–private partnerships accelerate cancer research and clinical trials in LMICs?

FFX/bevacizumab plus atezolizumab improves PFS in first-line dMMR/MSI-H mCRC

Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD Platform

Advancing clinical trials in Africa

Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer

Toripalimab plus chemotherapy improves 3-year survival in resectable gastric/GEJ cancer

Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma

Physical activity reduces fatigue and improves quality of life in colorectal cancer survivors

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer

Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation

MS-553 shows promise in treating chronic lymphocytic leukaemia

Enhancing cancer care in Africa: Patient perspectives and quality improvement